Retrovir™ (zidovudine)

21.08.2013 Updated 22.10.2019 5209 views

By MoH of Ukraine Order No. 727 of 16.08.13, there were approved the instructions for medical use (hereinafter, the instructions) of the original (reference) medicinal product containing zidovudine, namely Retrovir™, capsules, with amendments and additions to the following sections of the instructions: "Adverse reactions", "Special warnings and precautions for use", "Interaction with other medicinal products and other forms of interaction".